MCI Onehealth Technologies Inc. ("MCI Onehealth"
or the “Company") (TSX: DRDR), a clinician-led healthcare
technology company focused on increasing access to, and quality of
healthcare, has entered into a partnership with ReGen Scientific
Inc. (“ReGen”), a leading personalized, preventative, and
regenerative health provider in Canada. The ReGen team, led by Dr.
Robert Francis and Jean Marc Mackenzie, has an unparalleled track
record in individualized and concierge medicine in Canada. Dr.
Francis was the founder of Medcan Healthcare in 1987 and grew it
into one of the longest operating premium healthcare brands
specializing in executive medical, corporate wellness, and
concierge health services in Canada.
“We are excited to be working with MCI Onehealth
to not only harness the power of ReGen’s precision and predictive
health platforms, but to enhance the conclusive value of our tools
with MCI Onehealth’s technologies," said Jean-Marc MacKenzie, Chief
Executive Officer and Co-Founder of ReGen. “As the first step in a
long-term partnership, this is a very important moment in shaping
the future of innovation and precision care to help improve health
outcomes for Canadians and globally.”
MCI Onehealth will be engaging in a commercial
partnership with ReGen that is designed to allow for both parties
to further enhance the patient experience through a hybrid
approach. In-clinic excellence will be supported by
industry-leading technology, while simultaneously training MCI
Onehealth’s advanced intelligence platforms to provide physicians
the appropriate tools to offer patients an entirely new level of
quality and individualized care.
“MCI Onehealth’s partnership with ReGen
represents a powerful synergy of our respective strengths. Notably,
our 2 million patients of record will benefit from ReGen’s
leadership in the field of personalized and preventative medicine,”
said Dr. Alexander Dobranowski, MD, CEO of MCI Onehealth. “As we
continue to forge a new landscape in healthcare, this partnership
allows MCI Onehealth to advance our vision of the future of primary
healthcare delivery by incorporating precision and individualized
care into our ecosystem.”
Widely recognized as a pioneer in preventative
medicine and wellness in Canada for more than three-decades,
Chairman and Co-Founder of ReGen, Dr. Robert Francis will further
lend his expertise to MCI Onehealth by joining the Company’s Board
of Advisors. Dr. Francis brings a wealth of experience and a track
record of excellence, which will be a welcomed asset to the larger
MCI Onehealth ecosystem, as it continues its trajectory in building
a comprehensive and technologically advanced ecosystem for its
patients.
Additionally, a nominee of MCI Onehealth will be
joining ReGen’s Board of Directors to bring the proficiency of MCI
Onehealth’s leading primary care network and foremost technological
advances in precision medicine & primary healthcare innovation,
to the newly established ReGen institute.
“The MCI Onehealth and ReGen partnership
represents our joint commitment and passion for realizing the
promise of personalized & precision medicine. We look forward
to demonstrating how ReGen can support MCI Onehealth’s vision of
redefining the standard of primary care through an increased focus
on personalized, preventative, and precision medicine that changes
the way health is measured and care is delivered in Canada and
globally,” said Dr. Francis. “ReGen is the next evolution in our
commitment and passion for personalized medicine. ReGen seeks to
extend longevity, health span and vitality in those years lived by
leveraging the latest in science, medicine, health informatics, and
the identification and management of metabolic health.”
Alongside ReGen’s pioneering efforts in
precision medicine, individualized care, and leading edge clinic
and laboratory, this unique partnership further accelerates MCI
Onehealth’s strategic vision and roadmap toward a data-driven,
modernized technology-enabled health services platform.
About ReGen Scientific
ReGen Scientific, is a Toronto based leader in
personalized, preventative, and regenerative health. It is
accelerating the loop between discovery medical science and
evolutions in clinical and functional medicine. ReGen delivers
hyper-personalized care based on its Science of You, which enables
individuals to take control of their health with an objective of
not only extending years lived but the ability to live those years
with vitality and health. For more information, visit
regen.care
About MCI Onehealth:MCI
Onehealth is a healthcare technology company focused on empowering
patients and doctors with advanced technologies to increase access,
improve quality, and reduce healthcare costs. As part of the
healthcare community for over 30 years, MCI Onehealth operates one
of Canada’s leading primary care networks with 25 clinics, serves
over 850,000 patients annually and had over 200,000 telehealth
visits last year. MCI Onehealth additionally offers an expanding
suite of occupational health service offerings that support a
growing list of over 250 corporate customers. Led by a proven
management team of doctors and experienced executives, MCI
Onehealth remains focused on executing a strategy centered around
acquiring technology and health services that complement the
company’s current roadmap.
For more information,
visit mcionehealth.com
For IR enquiries please contact:Fernando
Massalin | Ir@mcionehealth.com | (416) 440-4040 ext 155
For media enquiries please contact:Braden
Rosner | braden@yprcanada.com | +1 (647) 982-8549
Forward-Looking Statements
This press release contains forward-looking
information and forward-looking statements (together,
“forward-looking statements”) within the meaning of applicable
securities legislation, which reflects MCI Onehealth’s current
expectations regarding future events, including statements relating
to: the relationship between the Company and ReGen (including the
expected benefits thereof), the impact of the relationship with
ReGen on MCI Onehealth’s service offering, the integration of ReGen
and MCI Onehealth’s services, Regen’s continued rapid growth and
accretive value to MCI Onehealth. In some cases, but not
necessarily in all cases, forward-looking statements can be
identified by the use of words or phrases such as “plans”,
“targets”, “expects”, “estimates”, “intends”, “anticipates”,
“believes”, or variations of such words and phrases or state that
certain actions, events or results “may”, “could”, “would”, “might”
or “will” occur. Forward-looking statements are based on a number
of assumptions and is subject to a number of risks and
uncertainties, many of which are beyond MCI Onehealth’s control,
which could cause actual results and events to differ materially
from those that are disclosed in or implied by such forward-looking
statements. Such risks and uncertainties include, the factors
discussed under “Risk Factors” in the Company’s annual information
form for the year ended December 31, 2020 which is available under
the Company’s profile on SEDAR at www.sedar.com. All
forward-looking statements made in this press release are made as
of the date hereof and MCI Onehealth does not undertake any
obligation to update such forward-looking statements, whether as a
result of new information, future events or otherwise, except as
expressly required by applicable law.
MCI Onehealth Technologies (TSX:DRDR)
Historical Stock Chart
From Jun 2024 to Jul 2024
MCI Onehealth Technologies (TSX:DRDR)
Historical Stock Chart
From Jul 2023 to Jul 2024